Chiesi USA, Inc.: CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary
Read the official notice at FDA (drug) →
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Chiesi USA, Inc.
- Product
- CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
- Reason / hazard
- Lack of Assurance of Sterility
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the United States
- Recall initiated
- 2026-07-06
- Code info
- Lot #: 1239521, 1237454, Exp. Date 10/2027
- Product quantity
- 44280 vials
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Cary
- State
- NC
- Country
- United States
- Event id
- 99376
Free daily digest + "My products" watchlist